The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

• Abnormal Interleukin-1 Receptor Type II Gene Expression in the Endometrium of Women with Endometriosis1 via openalex
• Angiogenic Factors in Endometriosis via openalex
• Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis via openalex
• Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
• Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis via openalex
• Decreased Expression of the Decoy Interleukin-1 Receptor Type II in Human Endometriosis via openalex
• Die Bedeutung der Angiogenese für die Pathogenese der Endometriose via openalex
• Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice via openalex
• Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro via openalex
• Endocrinology and paracrinology via openalex
• Endometrial angiogenesis throughout the human menstrual cycle via openalex
• Endometriosis: Interaction of Immune and Endocrine Systems via openalex
• Epidemiology of Endometriosis via openalex
• Immunobiology of endometriosis via openalex
• Immunohistochemical Study of Angiogenic Factors in Endometrium and Endometriosis via openalex
• Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium via openalex
• Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin via openalex
• Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
• Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
• Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
• Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease via openalex
• Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosis via openalex
• Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis via openalex
• Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
• Role of interleukin-1 receptor type II in the pathogenesis of endometriosis via openalex
• Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model via openalex
• Spontaneous Apoptosis of Endometrial Tissue is Impaired in Women with Endometriosis via openalex
• The epidemiology of endometriosis via openalex
• The Role of Cytokines in Endometriosis* via openalex
• W2137022580 via openalex
• W2137772824 via openalex
• W2161033554 via openalex
• W1515994079 via openalex
• W2411029809 via openalex
• W2477008945 via openalex
• W3193555215 via openalex
• W4233484287 via openalex
• W4238375162 via openalex
• W4240301403 via openalex
• W6628680024 via openalex
• W6677592361 via openalex
• W26755955 via openalex
• W6715348775 via openalex
• W2053212420 via openalex
• W2035458748 via openalex
• W2087050793 via openalex
• W2113913813 via openalex
• W2116101489 via openalex
• W2117021879 via openalex
• W2125499492 via openalex

Cited by (1)

• Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025

Source provenance

europepmc

last seen: 2026-06-23T06:15:44.889181+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:17:24.614948+00:00